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BACKGROUND: Long-term feeding with a high-fat diet (HFD) induces endothelial dysfunction in mice, but early HFD-induced 
effects on endothelium have not been well characterized.
METHODS AND RESULTS: Using an magnetic resonance imaging-based methodology that allows characterization of endothelial 
function in vivo, we demonstrated that short-term (2 weeks) feeding with a HFD to C57BL/6 mice or to E3L.CETP mice re-
sulted in the impairment of acetylcholine-induced response in the abdominal aorta (AA), whereas, in the thoracic aorta (TA), 
the acetylcholine-induced response was largely preserved. Similarly, HFD resulted in arterial stiffness in the AA, but not in the 
TA. The difference in HFD-induced response was ascribed to distinct characteristics of perivascular adipose tissue in the TA 
and AA, related to brown- and white-like adipose tissue, respectively, as assessed by histology, immunohistochemistry, and 
Raman spectroscopy. In contrast, short-term HFD-induced endothelial dysfunction could not be linked to systemic insulin re-
sistance, changes in plasma concentration of nitrite, or concentration of biomarkers of glycocalyx disruption (syndecan-1 and 
endocan), endothelial inflammation (soluble form of vascular cell adhesion molecule 1, soluble form of intercellular adhesion 
molecule 1 and soluble form of E-selectin), endothelial permeability (soluble form of fms-like tyrosine kinase 1 and angiopoietin 
2), and hemostasis (tissue plasminogen activator and plasminogen activator inhibitor 1).
CONCLUSIONS: Short-term feeding with a HFD induces endothelial dysfunction in the AA but not in the TA, which could be 
ascribed to a differential response of perivascular adipose tissue to a HFD in the AA versus TA. Importantly, early endothelial 
dysfunction in the AA is not linked to elevation of classical systemic biomarkers of endothelial dysfunction.
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Endothelial dysfunction is a hallmark of various diseases including metabolic syndrome,1 and the assessment of NO-dependent vasodilation in the 
coronary or peripheral circulation predicts adverse car-
diovascular events and poor long-term outcomes.2,3
In experimental conditions, in various models of en-
dothelial dysfunction, endothelium-dependent function 
in large and small vessels is classically studied in the 
myograph setups,4–6 and perivascular adipose tissue 
(PVAT) is usually removed for studies in isolated aorta 
preparation, even though this tissue has a well-docu-
mented influence on endothelial function.7
Indeed, PVAT plays an important role in the regu-
lation of vascular function.8,9 Under physiological con-
ditions, PVAT releases a number of adipokines, such 
as adipocyte-derived relaxing factor,10 which have a 
beneficial anticontractile effect on vascular function 
and are essential for the maintenance of vascular ho-
meostasis.11 Accumulation of PVAT, e.g., in obesity,12,13 
was associated with impaired anticontractile function 
as well as perivascular inflammation.14,15
Altogether, there is increasing experimental evi-
dence to suggest that both structural and functional al-
terations in PVAT, in obesity and metabolic syndrome, 
might contribute to endothelial dysfunction, increasing 
the risk for atherosclerosis and hypertension devel-
opment.15,16 Futhermore, there are numerous reports 
describing long-term effects (>8  weeks) of high-fat 
diet (HFD) feeding on endothelial function in mice.17–21 
However, to the best of our knowledge, there are no 
reports that have characterized the effects of short-
term HFD feeding on endothelial function, taking into 
account heterogeneous characteristics of PVAT in var-
ious parts of the aorta and their distinct sensitivity to 
HFD-induced inflammation.7,22,23
Regional differences in PVAT even within different 
regions of the same vessel, e.g., in the aorta, were re-
ported.7 In rodents, fat surrounding the thoracic aorta 
(TA) has brown adipose tissue–like characteristics, 
whereas periaortic fat in the abdominal aorta (AA) has 
similar features to white adipose tissue.7,24 Generally, 
brown PVAT shows resistance to HFD-induced inflam-
mation in the perivascular tissue22 in contrast to white 
PVAT, which is highly responsive to HFD with marked 
increases in macrophage infiltration and cytokine ex-
pression,23 leading to increases in oxidative stress.14 
CLINICAL PERSPECTIVE
What Is New?
• In the present study, using state-of-the-art 
magnetic resonance imaging-based assess-
ment of endothelial response in vivo in ves-
sels with intact perivascular adipose tissue, we 
demonstrated distinct effects of a high-fat diet 
on endothelial phenotype in the thoracic and 
abdominal aorta in mice.
• The results show that even a short-term 
(2  weeks) feeding with a high-fat diet results 
in severe endothelial dysfunction in the ab-
dominal aorta, whereas endothelial function in 
the thoracic aorta is resistant to early high-fat 
diet–induced dysfunction. This difference was 
ascribed to distinct perivascular adipose tis-
sue composition, with white adipose tissue–
like characteristics in the abdominal aorta and 
brown adipose tissue–like characteristics in the 
thoracic aorta.
What Are the Clinical Implications?
• Early endothelial dysfunction induced by fat 
load was also described in humans. Our results 
show that perivascular adipose tissue depots 
determine endothelial response to a high-fat 
diet promoting or preventing endothelial dys-
function even after short-term feeding; there-
fore, perivascular adipose tissue plays a key role 
in the regulation of endothelial function and rep-
resents an important target for diagnosis and 
vasoprotective therapy to be explored clinically.




DETC diethyldithiocarbamic acid 
sodium salt
E3L.CETP APOE*3-Leiden.human 
Cholesteryl Ester Transfer 
Protein transgenic mice
EPR electron paramagnetic 
resonance
eWAT epididymal white adipose 
tissue
GTT glucose tolerance test
HFD high-fat diet
iBAT interscapular brown adipose 
tissue
Phospho-eNOS phosphorylated endothelial NO 
synthase
PVAT perivascular adipose tissue
PWV pulse wave velocity





 http://ahajournals.org by on January 12, 2021
J Am Heart Assoc. 2020;9:e016929. DOI: 10.1161/JAHA.120.016929 3
Bar et al Heterogeneous Endothelial Response in HFD-Fed Mice
However, it is not known whether regional differences 
of PVAT in the aorta between AA and TA influence de-
velopment of endothelial dysfunction in the early phase 
of HFD.
Accordingly, the aim of the present study was to 
characterize a possibly distinct response of endothe-
lium in the AA and TA in relation to PVAT character-
istics (assessed by histology, immunohistochemistry, 
and Raman spectroscopy) after short-term (2, 4, and 
8 weeks) feeding with a HFD in mice. To assess en-
dothelial function in vivo, we used a 3-dimensional 
(3D) magnetic resonance imaging (MRI)-based 
method.25 This methodology does not have the lim-
itations of ex vivo vascular studies and allows study 
of endothelial function in vivo in the presence of in-
tact PVAT surrounding the studied vessel. To deter-
mine whether systemic effects of short-term HFD 
feeding might account for the observed differences 
in endothelium-dependent vasodilation in the TA and 
AA, we comprehensively assessed the systemic 
response to short-term HFD feeding by measuring 
insulin resistance, plasma concentrations of nitrite 
and nitrate, oxidative stress in red blood cells, and 
plasma concentration of various biomarkers of endo-
thelial dysfunction.26
METHODS
The data, analytic methods, and study materials will 
be made available on request to other researchers for 
purposes of reproducing the results or replicating the 
procedures.
Animals
Studies were performed in 6-week-old C57BL/6 male 
mice (from Mossakowski Medical Research Centre, 
Polish Academy of Sciences, Warsaw, Poland), fed 
a HFD (HFD60%, 60 kcal% of fat +1% of cholesterol; 
ZooLab, Krakow, Poland) for 2, 4, and 8  weeks 
(measurements at 8, 10, and 14  weeks of age, re-
spectively) in comparison to age-matched C57BL/6 
male mice fed a control diet (AIN93G, ZooLab). 
Moreover, to confirm that regional differences in en-
dothelial response in the aorta in response to a HFD 
can also be observed as early as after 2  weeks in 
another murine model, we chose APOE*3-Leiden.
human Cholesteryl Ester Transfer Protein transgenic 
(E3L.CETP) mice (from the Netherlands Organisation 
for Applied Scientific Research, Metabolic Health 
Research, Leiden, Netherlands), an established and 
well-recognized model for hyperlipidemia and athero-
sclerosis.27,28 The study was performed on 12-week-
old female E3L.CETP mice, at the stage before the 
development of endothelial dysfunction (A. Bar, PhD, 
unpublished results, 2020). E3L.CETP mice were 
fed a HFD containing cacao butter (HFD32%, 15% 
cacao butter (32  kcal%)+1% cholesterol, Charles 
River Laboratories) for 2 weeks (measurements at 
14 weeks of age) and 16 weeks (only glucose toler-
ance test [GTT] at 28 weeks of age) in comparison to 
age-matched C57BL/6J female mice (from Charles 
River Laboratories) fed a control diet (standard diet, 
Altromin, AnimaLab). The experiment involved 16 to 
18 mice per group in most of the end point measure-
ments but in some assessments (e.g., MRI measure-
ments) in which the biggest differences were expected 
in readouts, a lower number of animals (from 5 to 8) 
was used. The size of a given experimental group is 
reported in the legends of the corresponding graphs. 
Mice were housed in collective cages, in a room with 
constant environmental conditions (22–25°C, 65%–
75% humidity, and 12-hour light/dark cycle) and were 
weighed at the beginning and after 2, 4, and 8 weeks 
of feeding, presented as percentage weight changes 
after respective diet duration. Animals had ad libitum 
access to daily provided diets and water. All experi-
ments were approved by the local ethics committee 
of Jagiellonian University (Krakow, Poland, identi-
fication code: 82/2016 date of approval: May 31, 
2016) and were in accordance with the Guide for the 
Care and Use of Laboratory Animals of the National 
Academy of Sciences (National Instututes of Health 
publication No. 85–23, revised 1996), as well as the 
Guidelines for Animal Care and Treatment of the 
European Community.
Assessment of Insulin Resistance Based 
on GTT
Before GTT was performed, mice were fasted for 
4 hours with access to water. Baseline glucose level 
was measured using a standard glucometer in a drop 
of blood from the tail, cut at the end. Blood glucose 
concentration measurements were repeated after 15, 
30, 45, 60, and 120 minutes of intraperitoneal glucose 
administration (2 g/kg body weight). Results are pre-
sented as a curve of blood glucose concentration in 
time and as an area under the curve.
Assessment of Acetylcholine-Induced 
Vasodilation In Vivo by MRI
MRI experiments were performed using a 9.4 T scan-
ner (BioSpec 94/20, USR). During the MRI experiment, 
mice were anaesthetized using isoflurane (Aerrane, 
Baxter Sp. z o. o., 1.5 vol%) in oxygen and air (1:2) mix-
ture and imaged in the supine position. Heart function 
(rhythm and ECG), respiration, and body temperature 
(maintained at 37°C using circulating warm water) were 
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Endothelial function in vivo was assessed by a 
previously described technique25,29,30 as an endo-
thelium-dependent response to acetylcholine (Ach) 
administration. Response to injection of Ach (Sigma-
Aldrich; 50  μL, 16.6  mg/kg, IP: dose of Ach was 
based on a previous study25) was analyzed in the AA 
and TA.
Vasomotor responses were examined by compar-
ing 2, time-resolved 3D images of the vessels before 
and 25  minutes after intraperitoneal Ach administra-
tion. The optimal time to measure Ach-induced vaso-
relaxation was chosen based on our previous work.25 
3D images of the aorta were acquired using the cine 
IntraGate FLASH 3D sequence and reconstructed 
with the IntraGate 1.2.b.2 macro (Bruker). Analysis 
was performed using ImageJ software 1.46r (National 
Instututes of Health) and scripts written in MATLAB 
(MathWorks), in the hyperstack of the AA (10 slices 
in diastole, from the renal arteries down) and the TA 
(10 slices in diastole, from the celiac artery up). All 
cross-sectional areas of vessels at each slice were ob-
tained using thresholding segmentation and exported 
to MATLAB, where vessel volumes were reconstructed 
and calculated.
Imaging parameters included the following: repeti-
tion time—6.4 ms, echo time—1.4 ms, field of view—
30×30×14  mm3 for aorta, matrix size—256×256×35, 
flip angle—30°, and number of accumulations—15, re-
constructed to 7 cardiac frames. Total scan time was 
about 12 minutes.
Assessment of Aortic Pulse Wave Velocity
Pulse wave velocity (PWV) measurements were per-
formed using a Doppler flow velocity system (Indus 
Instruments, Scintica Instrumentation).31 During 
Doppler measurements, mice were anaesthetized 
using isoflurane (Aerrane; Baxter Sp. z o. o., 1.5 vol%) 
oxygen and air (1:2), mixture. Mice were taped supine 
to ECG electrodes incorporated into a temperature-
controlled printed circuit board. The temperature of 
each mouse was monitored with a rectal probe and 
body temperature was maintained at 37°C. Before 
measurements, the chest and right hind limb of the 
mice were shaved.
The PWV, an index of arterial stiffness,32 was 
measured using two 20-MHz Doppler probes, by si-
multaneously recording velocity signals from 2 sites, 
representative for the TA and AA. The TA measure-
ments were performed by measuring velocities in the 
aortic arch and in the descending aorta about 15 to 
20  mm distal to the first probe. To obtain a signal 
from the descending aorta, the probe was placed 
just under the sternum and angled toward the heart 
at a depth of 4 mm. Measurements in the TA were 
performed by placing the second probe tip at the 
base of the left upper limb, oriented almost parallel 
to the board surface and aimed toward the upper 
mid-chest at a depth of 6  mm. The AA measure-
ments were performed by measuring the velocities 
in the descending aorta and ≈25 to 30 mm distal to 
the first probe in the right femoral artery by placing 
the second probe on the right hind limb of the mice 
and angled toward the murine groin at a depth of 
3 to 4 mm. Aortic PWV was calculated by dividing 
the separation distance by the difference in arrival 
times of the velocity pulse timed with respect to the 
ECG.31 Signal analysis was performed using Doppler 
signal processing workstation (version 1.625, Indus 
Instruments).
Blood Sampling and Tissue Collection
At the end of the experiment, mice were anaesthe-
tized (100  mg/kg ketamine+10  mg/kg xylazine, IP) 
and blood was drawn from the heart and collected 
in tubes containing 10% solution of ethylenediami-
netetraacetic acid dipotassium salt (Aqua-Med; 
1  μL of EDTA/100  μL of blood). Next, blood was 
mixed with MS-SAFE Protease and Phosphatase 
Inhibitor (Sigma-Aldrich) in a ratio of 100:1. All sam-
ples were centrifuged at 664g, at a temperature of 
4°C for 10 minutes to isolate plasma, as previously 
described.26 Obtained plasma samples were deep-
frozen at −80°C for high-performance liquid chroma-
tography measurements of nitrate (NO−
3
) and nitrite 
(NO−
2
) concentrations by ENO-20 NOx Analyser as 
well as for microLC/MS-MRM measurements of bio-
markers of endothelial dysfunction. The remaining 
blood was deep-frozen at −80°C for measurements 
of glutathione concentration in red blood cells as de-
scribed below. Aorta, PVAT, and liver were collected 
for further ex vivo assessments as described below. 
Moreover, liver, as well as perirenal adipose tissue 
and epididymal adipose tissue, were weighted after 
collection.
Histological Assessment of Liver 
Steatosis
Liver sections were stained with Oil Red O for lipids 
visualization, and at least 9 images of each liver were 
randomly obtained under ×200 magnification. In de-
tail, the image segmentation was performed using 
simple intensity thresholding. First, the source image 
was thresholded to extract the tissue image from 
the background, next within the tissue area another 
thresholding step was performed to obtain red, Oil 
Red O–stained lipids droplets mask. Finally, the area 
of the background, tissue, and lipid droplets were 
calculated. Liver steatosis was expressed as the per-
centage of fat area versus tissue area, calculated in 




 http://ahajournals.org by on January 12, 2021
J Am Heart Assoc. 2020;9:e016929. DOI: 10.1161/JAHA.120.016929 5
Bar et al Heterogeneous Endothelial Response in HFD-Fed Mice
Storage and Analysis System (PerkinElmer) with an 
algorithm adapted for quantitative analysis of Oil Red 
O–stained sections. Similar results were obtained 
after calculation of oil area versus background image 
area in the left liver lobe, as well as in the entire tis-
sue of the liver. Therefore, other parameters were not 
presented.
Characteristic of PVAT of the TA and AA 
by Immunohistochemistry
Formalin-fixed and paraffin-embedded thoracic and 
abdominal parts of the aorta with PVAT were cut into 
5-μm slices. Antigen retrieval was performed ac-
cording to the standard protocol. Area of the brown 
and white adipose tissue in PVAT was assessed by 
double staining using perilipin and UCP-1 (uncou-
pling protein 1) antibodies. To visualize the total PVAT 
area, a perilipin antibody (primary anti–perilipin-1 
antibody, ab61682) was used, whereas the area 
of brown adipose tissue was identified by UCP-1 
staining (primary anti–UCP-1 antibody, ab209483). 
Sections were incubated with the secondary anti-
bodies FITC-conjugated donkey anti-goat IgG (705-
454-003) and Cy3-conjugated donkey anti-rabbit 
(711-165-152). To characterize the functional differ-
ences between brown and white adipose tissue, the 
lectin I and phosphorylated endothelial NO synthase 
(Phospho-eNOS) were stained. To visualize glyco-
calyx of microvessels in PVAT, biotinylated Lectin I 
(B-1105) was used. Phospho-eNOS—Ser1177 (9571) 
(primary Phospho-eNOS [Ser1177] antibody, #9571) 
was used to detect inflammatory processes in en-
dothelium. Then, sections were incubated with the 
secondary antibody biotinylated-conjugated goat 
anti-rabbit IgG (111-065-003). Then the slices were 
incubated with VECTASTAIN Elite ABC-HRP Kit and 
diaminobenzidine (Sigma) to obtain the colour reac-
tion. Subsequently, the cross-sections of the TAs and 
AAs with PVAT were photographed (×100 magnifica-
tion) and images were acquired using an AxioCam 
MRc5 digital camera and an AxioObserver 22 D1 
inverted fluorescent microscope (Zeiss) or BX51 mi-
croscope (Olympus). Before analysis in the pictures 
with Lectin I and Phospho-eNOS nonadipose tissue 
(aorta, muscles, lymph nodes) fragments were man-
ually excised. Image segmentation was performed 
using Ilastik (developed by the Ilastik team, with par-
tial financial support of the Heidelberg Collaboratory 
for Image Processing, HHMI Janelia Farm Research 
Campus and CellNetworks Excellence Cluster). 
The pixels corresponding to the UCP-1 immunopo-
sitive area, as well as perilipin immunopositive area 
(FITC channel), were quantitatively determined using 
ImageJ software 1.46r as demontrated in Figure S1. 
The mean number of pixels representing UCP-1 and 
perilipin were counted using ImageJ software. The 
results were expressed as the ratio of brown adipose 
tissue area (number of UCP-1 immunopositive pixels/
PVAT area), area of mirovessels (number of Lectin I 
immunopositive pixels/PVAT area), or activated en-
dothelium (Phospho-eNOS immunopositive pixels/
PVAT area) and normalized to the respective control.
Characteristic of PVAT of the TA and AA 
by Raman Spectroscopy
Samples of the interscapular brown adipose tissue 
(iBAT), epididymal white adipose tissue (eWAT; from 
the adipose tissue attached to the epididymis and tes-
ticle), and PVATs of the TA and AA were isolated from 
wild-type C57BL/6J male mice fed an AIN93G or HFD 
for 4 weeks. Periaortic PVAT samples of the TA and 
AA were extracted from the descending aorta distal to 
the aortic arch and from the part of the artery lying in 
the abdominal cavity, respectively. For Raman spec-
troscopic measurements, all samples were rinsed in 
NaCl isotonic solution to wash traces of blood and put 
onto CaF2 slides as previously described.
33
The Raman spectra of the iBAT, eWAT, and PVAT 
samples were acquired using a confocal WITec Alpha300 
Raman spectrometer (WITec) equipped with a 532-nm 
laser, 20× air objective (Nikon S Plan Flour, numerical aper-
ture=0.45), UHTS 300 spectrograph (600 grooves·mm−1 
grating), and CCD detector (Andor, DU401A-BV-352). For 
each sample, at least 5 single Raman spectra were col-
lected using the maximum laser power at the sample po-
sition (≈28 mW). The single spectra of 32 accumulations 
and the integration time of 0.5 second were normalized in 
the 1800 to 400 cm−1 spectral range and averaged over 
all mice for each studied adipose tissue type.
All Raman spectra underwent routine preprocess-
ing including baseline correction using an autopolyno-
mial of degree 3 and an automatic cosmic ray removal 
procedure. Preprocessing was performed using the 
WITec Project Plus software. Raman spectra were av-
eraged per type of adipose tissue and presented using 
the OriginPro 9.1 program. The OPUS 7.2 program 
was used for calculations of the integral intensity (I) of 
the bands at ca. 1660 and 1445 cm−1, enabling estima-
tion of the lipid unsaturation degree (I1660/I1445). The 
results were tested by ANOVA performed using Prism 
software (GraphPad Software, Inc.) to characterize the 
differences in unsaturation of lipids in various types of 
the adipose tissue in a quantitative manner.
Assessment of Endothelial NO Production 
in the Aorta Using Electron Paramagnetic 
Resonance
For measurements of eNOS-dependent NO pro-
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spin-trapping with diethyldithiocarbamic acid so-
dium salt (DETC) was used ex vivo, as previously 
described,34 with minor modifications. The isolated 
aorta was divided into 2 parts: the abdominal and 
thoracic sections. Only half of the group of sam-
ples of the AA and TA were cleared from surround-
ing tissue, and the other half were analyzed in the 
presence of PVAT. Parts of the aorta were opened 
longitudinally and preincubated with 10  μmol/L of 
N6-(1-Iminoethyl)-lysine, hydrochloride (L-NIL) in 
Krebs-HEPES buffer for 30 minutes at 37°C. Addition 
of L-NIL during the preincubation period allowed the 
direct measurements of NO produced by eNOS with-
out the signal from NO produced by inducible NO 
synthase expressed by macrophages in atheroscle-
rotic plaque,35 as previously described.30,34,36 Next, 
DETC (3.6 mg) and FeSO4·7H2O (2.25 mg) were sep-
arately dissolved under argon gas bubbling in two 
10-mL volumes of ice-cold Krebs–Hepes buffer and 
were kept under gas flow on ice until use. After pre-
incubation, a spin trap (125 μL of FeSO4·7H2O and 
125 μL of DETC—final concentration of the colloid: 
285 μmol/L) and calcium ionophore A23187 (the final 
concentration: 1 μmol/L) were added to the parts of 
aorta. Subsequently, incubation for 90  minutes at 
37°C was started. Finally, dried aorta was weighed 
and frozen in liquid nitrogen (suspended in fresh 
buffer) into the middle of a 400-μL column of Krebs–
Hepes buffer and stored at −80°C until measured. 
EPR spectra were obtained using an X-band EPR 
spectrometer (EMX Plus), equipped with a rectangu-
lar resonator cavity H102. Signals were quantified by 
measuring the total amplitude of the NO-Fe(DETC)2 
after correction of baseline. The quantitative results 
of NO production assessed by EPR were expressed 
in AU/mg of tissue and normalized to the respective 
controls.
Assessment of Reduced Glutathione and 
Oxidized Glutathione in Red Blood Cells 
by Capillary Electrophoresis
A P/ACE MDQ capillary electrophoresis system 
(Beckman Coulter) with 32 Karat software (version 
8.0, Beckman Coulter) was used for analyses. The 
apparatus was equipped with a PDA detector set at 
200 nm. Separation of the analytes took place in an 
uncoated fused-silica capillary (60.2  cm total length, 
50  cm effective length, 50 μm ID, and 375 μm OD) 
thermostated at 25°C with a constant voltage of 25 kV 
(≈6.5 μA). BisTRIS (75 mmol/L), boric acid (25 mmol/L) 
buffer adjusted to pH 7.8 by adding 1  mol/L NaOH, 
was chosen as a background electrolyte. Samples 
were introduced to the capillary by hydrodynamic in-
jection for 20 seconds by 3.5 kPa, followed by injection 
of ultrapure H2O for 2 seconds by 3.5 kPa. Between 
analytical runs, the capillary was rinsed with 1 mol/L 
of NaOH, ultrapure water, and background electro-
lyte, respectively (138 kPa; 2 minutes each). Obtained 
data were analyzed by PeakFit software (version 4.12, 
Systat Software).
Measurements of reduced glutathione and oxi-
dized glutathione were performed as described by 
Hempe et al.37 Briefly, red blood cells were first sep-
arated from plasma by centrifuging whole blood. A 
hemolysate was prepared by adding to 50 μL of red 
blood cells, 200 μL of hemolyzing reagent (10 mmol/L 
KCN and 5  mmol/L EDTA in ultrapure H2O). Then, 
samples were deproteinated by adding 100  μL of 
5% metaphosphoric acid to 100 μL of hemolysate. 
After centrifugation (10 000g for 10 minutes at 4°C), 
the metaphosphoric acid extracts were diluted 1:4 
with ultrapure H2O and then used for capillary elec-
trophoresis analysis. All chemicals except boric acid 
(J.T. Baker) and NaOH (VWR International) were pur-
chased from Sigma-Aldrich.
Assessment of Biomarkers of Endothelial 
Dysfunction in Plasma by MicroLC/MS-MRM
Assessment of 10 protein biomarkers of endothelial 
dysfunction was performed using a microLC/MS-
MRM method as previously described.26,30,38–40 The 
panel included biomarkers of various aspects of en-
dothelial dysfunction such as glycocalyx disruption: 
syndecan-1 and endocan; endothelial inflammation: 
soluble form of vascular cell adhesion molecule 1, 
soluble form of E-selectin and soluble form of in-
tercellular adhesion molecule 1; endothelial perme-
ability: angiopoietin 2 and soluble form of fms-like 
tyrosine kinase 1; and hemostasis: von Willebrand 
factor, tissue plasminogen activator and plasmino-
gen activator inhibitor 1.
A UPLC Nexera system (Shimadzu) connected to 
a highly sensitive mass spectrometer QTrap 5500 
(Sciex) was used. During sample preparation, the 
murine plasma was subjected to proteolytic diges-
tion using porcine trypsin to achieve unique and 
reproducible peptide sequences, applied as the 
surrogates of the proteins suitable for LC-MS/MS 
analyses. A detailed description of the targeted anal-
ysis of a selected panel of proteins was presented 
elsewhere.26,38,39
Statistical Analysis
The study included separated mice groups to col-
lect organs and tissue for further analysis after 2, 
4, and 8 weeks of HFD feeding. Data are presented 
as mean and SD or in the case of a lack of normal 
distribution (Shapiro–Wilk test), as median and inter-
quartile range. Statistical tests were performed using 
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or Mann–Whitney U test) or parametric (1- and 2-way 
ANOVA with Tukey test, repeated measures ANOVA, 
unpaired t Student test) tests were performed. A 
value of P≤0.05 was considered to be statistically 
significant.
RESULTS
General Characteristics of C57BL/6 Mice 
Fed a HFD (HFD60%) for 2 to 8 Weeks
Effects of feeding with an HFD60% were manifested by 
insulin resistance, as evidenced by an increased level of 
blood glucose concentration in GTT. In C57BL/6 mice 
fed an HFD60% for only 2 weeks, the area under the 
GTT curve was significantly increased (area under the 
curve ≈2-fold higher in C57BL/6 mice fed a HFD60%, in 
comparison to C57BL/6 mice fed a standard diet), and 
was maintained at a similar level after 4 and 8 weeks of 
HFD60% feeding (Figure 1B).
HFD60% also induced mild liver steatosis that was 
similar after 2, 4, and 8 weeks of HFD60% (in a range 
between 9.1% and 14.7% as compared with 1.0% in 
mice fed a standard diet; Figure 1E). Early liver steato-
sis was not associated with changes in body weight 
(Figure 1A), liver mass (liver mass ≈1.0 g in all exper-
imental groups), or changes in the mass of epididy-
mal (Figure  1C) and perirenal (Figure  1D) adipose 
tissue. However, after 4 and 8 weeks of an HFD60%, 
the masses of epididymal adipose tissue and perirenal 
adipose tissue were ≈2- and 3-fold higher, respectively, 
and body weight also changed (by 20% in comparison 
to mice fed a standard diet).
Early Impairment of Acetylcholine-
Induced Vasodilation and NO Production 
in the AA But Not in the TA in C57BL/6 
Mice Fed HFD (HFD60%)—the Relationship 
With PVAT Characteristics
After 2  weeks’ feeding of C57BL/6 mice with an 
HFD60%, impairment of Ach-induced vasodilation in the 
AA (Figure 2B) was observed as paradoxical vasocon-
striction (volume changes of the AA: −27.8% in com-
parison to 13.7% in age-matched control mice) with 
progression of endothelial dysfunction in HFD60% mice 
after 4 and 8  weeks of HFD60% feeding. In contrast, 
Ach-induced vasodilation in the TA was fully preserved 
throughout the 2- to 8-week period of HFD60% feeding 
(Figure 2A).
Moreover, 4 to 8  weeks of feeding with HFD60% in-
duced arterial stiffness as evidenced by an increased 
value of the PWV in the AA (≈1.5-fold increase of PWV 
in comparison to control mice, Figure S2B), which was 
not observed in the TA (Figure S2A).
Differential response to HFD60% of the AA and TA 
was also confirmed by EPR measurements of NO pro-
duction in aorta ex vivo (Figure 3A through 3D). In aorta 
with preserved PVAT, NO production level was main-
tained in the TA (Figure 3A) and decreased (≈30%) in 
the AA (Figure 3B) in HFD60%-fed mice in comparison 
to control mice. Furthermore, impaired NO production 
in the aorta with and without PVAT was observed in the 
AA (Figure 3D) but not in the TA (Figure 3C).
The difference in the AA and TA response to a short 
period of HFD60% was associated with distinct char-
acteristics of PVAT in the TA and AA, related to brown 
and white adipose tissue, respectively. In fact, 2 weeks 
of HFD60% feeding induced a nonsignificant fall (P=0.2) 
in the amount of brown adipose tissue in the AA, which 
was even more pronounced and significant (≈2.5-fold 
decrease of brown adipose tissue amount) after 4 to 
8 weeks of HFD60% (P=0.02 and P=0.03, respectively) 
(Figure 2D and 2F), whereas in the TA, HFD60% feeding 
did not induce any significant changes in the amount 
of brown fat tissue in PVAT (Figure 2C and 2E) after 2, 
4, or 8 weeks of HFD feeding. Furthermore, 2 weeks 
of HFD60% feeding induced a significant increase in 
the lectin (Figure S3A and S3B) and a decrease in the 
Phospho-eNOS (Figure S3C and S3D) contents in PVAT 
of the aorta, with the latter change more pronounced 
in the AA (lectin: 12% higher, Phospho-eNOS: 11% 
lower in comparison to control mice; Figure S3B and 
S3D) than in the TA (lectin: 6% higher, Phospho-eNOS: 
7% lower in comparison to control mice; Figure S3A 
and S3C), although the observed difference was not 
statistically significant.
To confirm AA and TA differential response to 
HFD60%, the lipid unsaturation degree was estimated 
by Raman spectroscopy in PVAT of the TA (Figure S4A) 
and AA (Figure S4B) in mice after 4 weeks of HFD60% 
feeding and compared with this parameter for the iBAT 
(Figure S4C) and eWAT (Figure S4D). HFD60% feeding 
induced a statistically significant (14%) decrease in lipid 
unsaturation in the PVAT of the AA that was qualitatively 
similar to a reduction of lipid unsaturation in the white 
adipose tissue in eWAT (20%). The decrease of lipid 
unsaturation was manifested as a decreased intensity 
of Raman bands at 1660 and 1268 cm−1 assigned to 
the C=C stretching and =C–H deformation vibrations, 
respectively, and increased intensity of the band at 
1445 cm−1, attributable to the CH bending vibrations.41 
Thus, the ratio of the integral intensities of bands at 
1660 and 1445 cm−1 was chosen to assess the lipid 
unsaturation as shown in Figure S3. In contrast to the 
AA and eWAT, HFD60% feeding did not influence lipid 
unsaturation in the PVAT of TA, nor in the iBAT brown 
adipose tissue.
Collectively, the Raman spectroscopy measure-
ments showed similar biochemical response in 
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Figure 1. Effects of high-fat diet (HFD; HFD60%) feeding on weight of mice, insulin resistance, 
epididymal and perirenal adipose tissue, and liver steatosis.
Changes in mice weight (A, WeightEnd–WeightStart/WeightStart), area under the glucose tolerance test (GTT) 
curve (B), mass of epididymal adipose tissue (EAT mass, C), and perirenal adipose tissue (PAT mass, D) as well 
as representative images of liver steatosis (E) in C57BL/6 mice fed an HFD (HFD60%, white columns) for 2 (n=16, 
A through C; n=15, D), 4 (n=16), and 8 (n=18) weeks in comparison to age-matched C57BL/6 mice fed a control 
diet (black columns, after 2 [n=16, A through C; n=15, D], 4 [n=16], and 8 [n=16, B through D; n=15, A] weeks of 
feeding). Statistics: 2-way ANOVA followed by Tukey post hoc test (normality was assessed using the Shapiro–
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Figure 2. High-fat-diet (HFD; HFD60%) feeding reduces endothelial function in the abdominal 
aorta (AA) in association with decreased brown fat in perivascular adipose tissue.
Changes in end-diastolic volume of the thoracic aorta (TA; A, TA-Ach) and AA (B, AA-Ach) 
25 minutes after acetylcholine (Ach) administration and ratio of brown adipose tissue area to total 
adipose tissue area as well as representative images of perivascular adipose tissue (PVAT) in the 
TA (C and E) and the AA (D and F) in C57BL/6 mice fed an HFD (HFD60%, white columns) for 2 (n=6, 
E and F; n=5, A and B), 4 (n=6, A and E; n=5, B and F), and 8 (n=7, B; n=6, A; n=5, E and F) weeks 
in comparison to age-matched C57BL/6 mice fed a control diet (black columns, after 2 [n=7, B; 
n=6, A; n=5, E, and F], 4 [n=6, A and B; n=5, E and F], and 8 [n=8, F; n=7, E; n=6, A and B] weeks 
of feeding). Statistics: 2-way ANOVA followed by Tukey post hoc test (normality was assessed 
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Figure 3. Effects of high-fat diet (HFD; HFD60%) feeding on NO production in the aorta, nitrite concentration in plasma, and 
level of reduced glutathione (GSH) and oxidized glutathione (GSSG) in red blood cells.
Changes in NO production in the thoracic aorta (TA; A and C) and the abdominal aorta (AA; B and D), cleared (C and D) or 
not (A and B) from surrounding adipose tissue, measured by spin-trapping with DETC (sodium diethyldithiocarbamate, spin 
trap), changes in nitrite (E, NO−
2
) concentration in plasma, and ratio of GSH and GSSG in red blood cells (F, GSH/GSSG) in 
C57BL/6 mice fed an HFD (HFD60%, white columns) for 2 (n=16, E; n=13, F; n=8, A and B; n=7, C and D), 4 (n=16, E; n=15, F; 
n=8, A through D), and 8 (n=19, E; n=18, F; n=9, A, B, and D; n=8, C) weeks in comparison to age-matched C57BL/6 mice 
fed a control diet (black columns, after 2 [n=16, E and F; n=8, A and B; n=7, D; n=6, C], 4 [n=16, E; n=15, F; n=8, A through 
D], and 8 [n=16, E; n=15, F; n=9, C; n=8, D; n=7, A and B] weeks of feeding). Statistics: 2-way ANOVA followed by Tukey post 
hoc test (normality was assessed using the Shapiro–Wilk test): not statistically significant (ns) *P<0.05, **P<0.01, ***P<0.001. 
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similar response in PVAT of the TA and in brown 
adipose tissue. These results suggest a relative in-
crease in saturated fatty acids in PVAT surrounding 
the AA, which did not occur in PVAT adjacent to 
the TA.
Lack of Early Changes in Plasma 
Concentration of Nitrite and Nitrate and of 
Biomarkers of Endothelial Dysfunction in 
C57BL/6 Mice Fed a HFD (HFD60%)
Feeding of C57BL/6 mice with a HFD from 2 to 
8  weeks did not affect NO−
2
 (Figure  3E) and NO−
3
 
concentration in plasma (average NO−
3
 plasma con-
centration, throughout diet duration in C57BL/6 con-
trol mice: 36.1±7.7 μmol/L and HFD60% fed C57BL/6 
mice: 35.9±10.7  μmol/L), whereas a change in re-
duced glutathione/oxidized glutathione ratio (≈a 
3-fold decrease in comparison to mice fed a stand-
ard diet; Figure 3F) was only seen after 8 weeks of 
HFD60% feeding. Moreover, with the exception of in-
creased plasma concentration of von Willebrand fac-
tor (concentration increased on average by ≈25%, in 
comparison to mice fed a standard diet, Figure 4H), 
there were no significant changes in plasma concen-
tration of biomarkers of glycocalyx disruption (synde-
can-1 and endocan; Figure 4A and 4B), endothelial 
inflammation (soluble form of vascular cell adhe-
sion molecule 1, soluble form of intercellular adhe-
sion molecule 1 and E-selectin; Figure  4C through 
4E), endothelial permeability (soluble form of fms-like 
tyrosine kinase 1 and angiopoietin 2; Figure 4F and 
4G), and hemostasis (tissue plasminogen activator 
and plasminogen activator inhibitor 1; Figure 4I and 
4J) in HFD60%-fed mice as compared with mice fed 
a control diet.
Therefore, biomarkers of endothelial function were 
not sensitive to detect endothelial dysfunction after 
short-term HFD60% feeding in contrast to the assess-
ment of functional endothelial response measured in 
vivo.
Early Impairment of Acetylcholine-
Induced Vasodilation in the AA But Not 
in the TA in E3L.CETP Mice Fed a HFD 
(HFD32%)
To confirm that regional differences in the early en-
dothelial response in the AA and the TA to HFD is not 
limited to one murine model we also studied E3L.CETP 
mice. Similarly to HFD60% feeding in C57BL/6 mice, 
2  weeks of feeding with HFD32% in E3L.CETP mice 
resulted in paradoxical vasoconstriction in the AA in-
duced by Ach (Figure 5D volume changes of the AA: 
−4.2% in comparison to 5.3% in age-matched control 
mice). However, Ach-induced vasodilation in the TA 
was fully preserved (Figure 5C).
HFD32% did not induce significant insulin resistance 
after short-term feeding (area under the curve: ≈1.8-
fold higher in E3L.CETP mice fed with HFD32% only after 
16 weeks of feeding, in comparison to C57BL/6J mice 
fed standard diet; Figure  5A). Moreover, 2  weeks of 
HFD32% feeding was not associated with the changes 
in body weight in the E3L.CETP mice (Figure 5B) and 
did not affect NO−
2




Altogether, in E3L.CETP mice fed a HFD32%, even 
though insulin resistance was not present, the impair-
ment of endothelial function in the AA (but not in the 
TA) was clearly observed.
DISCUSSION
Using an MRI-based methodology to assess endothe-
lial function in vivo,25 in vessels with intact PVAT, to the 
best of our knowledge, we demonstrated for the first 
time, that short-term feeding with a HFD resulted in 
endothelial dysfunction in the AA, whereas endothelial 
function in the TA was resistant to early HFD-induced 
dysfunction. These changes were independently ob-
served in 2 different murine models, C57BL/6 and 
E3L.CETP mice, fed a HFD of different composition, 
and were thereby independent of systemic insulin re-
sistance. Endothelial dysfunction in HFD-fed mice for 
2 weeks was not associated with systemic changes 
in NO bioavailability and changes in reduced glu-
tathione/oxidized glutathione ratio in red blood cells as 
the latter was only observed after 8 weeks of HFD60% 
feeding, supporting an increase in systemic oxidative 
stress after 8  weeks but not after 2  weeks of HFD 
feeding. Futhermore, the concentration of biomarkers 
of glycocalyx disruption (syndecan-1 and endocan), 
endothelial inflammation (soluble form of vascular 
cell adhesion molecule 1, soluble form of intercellu-
lar adhesion molecule 1 and E-selectin), endothelial 
permeability (soluble form of fms-like tyrosine kinase 
1 and angiopoietin 2), and hemostasis (tissue plas-
minogen activator and plasminogen activator inhibi-
tor 1) were not significantly altered. In contrast, these 
biomarkers changed typically in other models of en-
dothelial dysfunction in our previous studies.30,39,42 
The heterogeneous endothelial response in the ab-
dominal and thoracic parts of the aorta in response 
to short-term feeding with a HFD was ascribed to a 
distinct difference in the composition of white- and 
brown-like adipose tissue of PVAT in the AA and TA, 
as assessed by histology, immunohistochemistry, and 
Raman spectroscopy. Furthermore, the different en-
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by deterioration of arterial stiffness in the AA but not 
in the TA, underscoring the distinct functional conse-
quences of PVAT-modulated endothelial response for 
the entire vascular wall. Altogether, our results support 
the notion of the important role of PVAT in the early 
phase of HFD-induced vascular dysfunction operating 
in some but not in all vessels that could not be de-
tected on the basis of classical systemic biomarkers 
of endothelial dysfunction. These results underscore 
the insidious nature of early endothelial dysfunction in 
response to fat overload.
To assess endothelial function in vivo, in vessels 
with intact PVAT, a 3D MRI-based methodology was 
used. This methodology is well suited for detection and 
quantification, with good sensitivity and reproducibility, 
of NO-dependent endothelial response, and has been 
previously used to characterize endothelial function in 
the different murine models in vivo.25,29,30,43
In the present study, we focused on the short-term 
effects of a HFD, in particular after a 2-week period 
of HFD in C57BL/6 mice, a model that is character-
ized by the early development of insulin resistance and 
liver steatosis. The salient finding of this study was 
the detection of severe endothelial dysfunction after 
only 2  weeks of HFD60% feeding, as evidenced by a 
substantial impairment of Ach-induced vasodilation in 
the AA, which was reverted to vasoconstriction, the 
magnitude of which was even more pronounced as 
compared with previously studied 28-week-old ApoE/
LDLR-/- mice with advanced atherosclerosis.30
Our in vivo MRI-based approach revealed the ro-
bust impairment of endothelial function in the AA (but 
not in the TA) after 2  weeks of feeding with a HFD, 
which was barely detectable using ex vivo settings in 
previous work even after 4  weeks of a HFD,44,45 but 
was clearly present after 16 to 20 weeks of a HFD17,21 
or an even longer feeding (eg, 8  months20). Indeed, 
previously, only a marginal effect was seen in isolated 
aorta ex vivo after a short period of 4 weeks of HFD 
feeding in the magnitude of Ach-induced vasodilation, 
insulin-dependent vasodilation, or magnitude of phen-
ylephrine-induced vasoconstriction.44–46
We also demonstrated that HFD-induced endothe-
lial dysfunction progressed into the development of ar-
terial stiffness, which was observed as increased PWV 
in the AA after 4 to 8 weeks but not after 2 weeks of 
HFD feeding. Arterial stiffness of the TA did not change, 
again underscoring the regional differences between 
the AA and TA in response to a short-term HFD.
In addition to the assessment of PVAT characteris-
tics in the AA and TA by histology and immunohisto-
chemistry, Raman spectroscopy revealed that PVAT in 
the AA and TA displayed a different profile of lipid un-
saturation, showing striking similarities between PVAT 
in the AA and eWAT as well as between PVAT in the 
TA and iBAT. These observations confirm the notion 
that PVAT in the AA and TA shows a predominantly 
white and brown phenotype, respectively, in line with 
our previous report using Raman spectroscopy–based 
assessment of PVAT in the aorta in ageing mice41 and 
with other studies showing distinct characteristics of 
PVAT in the TA and the AA in mice.7,22,24,47 Most im-
portantly, a significant decrease of lipid unsaturation in 
PVAT of AA (and eWAT) was observed in response to 
HFD60% feeding, whereas PVAT of TA (and iBAT) was 
resistant to the increased amount of saturated lipids in 
the diet. The heterogeneous response of the AA and 
TA was also observed in EPR measurements in the ex 
vivo aorta, suggesting that the vasoprotective activity 
of PVAT was lost in the AA but not in the TA. Altogether, 
our results reveal that these 2 distinct PVAT depots 
have essentially antagonistic functions on endothelial 
function in the aorta in response to an HFD that either 
promote or prevent endothelial dysfunction in the AA 
and TA, respectively.
It should be underlined that there is not a clear divi-
sion in pure brown adipose tissue or pure white adipose 
tissue between these 2 PVATs because infiltrations of 
one type of PVAT can be found in the other.7 White 
adipose tissue, which is composed of adipocytes with 
a large, single fat droplet, is presumed to be the main 
depot for lipid storage also in perivascular tissue48 that 
is highly responsive to HFD.23 Conversely, brown PVAT, 
which contains several smaller fat droplets and numer-
ous mitochondria, displays vasoprotective activity,22 
participates in the regulation of intravascular tempera-
ture49 and shows resistance to a HFD; thus, it protects 
the vascular wall against diet-induced inflammation, as 
well as against atherosclerosis.22,49
To confirm that heterogenous early effects of HFD 
feeding on endothelium in the TA and AA could be 
detected by MRI in vivo in another model as well, 
Figure 4. Effects of high-fat diet (HFD; HFD60%) feeding on plasma concentration of protein biomarkers of endothelial dysfunction.
Concentrations of syndecan-1 (SDC-1) (A), endocan (ESM-1) (B), soluble form of vascular cell adhesion molecule 1 (sVCAM-1) (C), soluble 
form of intercellular adhesion molecule 1 (sICAM-1) (D), soluble form of E-selectin (sE-sel) (E), soluble form of fms-like tyrosine kinase 
1 (sFLT-1) (F), angiopoietin 2 (Angpt-2) (G), von Willebrand factor (vWF) (H), tissue plasminogen activator (t-PA) (I), and plasminogen 
activator inhibitor 1 (PAI-1) (J) in plasma, in C57BL/6 mice fed a HFD (HFD60% white columns) for 2 (n=16, C through J; n=15, A and B), 4 
(n=16, A through G, I, and J; n=14, H), and 8 (n=19, B, and D through J; n=18, A and C) weeks in comparison to age-matched C57BL/6 
mice fed a control diet (black columns, after 2 [n=16, B, H, and I; n=15, D; n=12, C, E through G, and J; n=11, A], 4 [n=16, A through G, I, 
and J; n=15, H], and 8 [n=16, B, D, G through I; n=15, A, C, E, F, and J] weeks of feeding). Statistics: B and I, 2-way ANOVA followed by 
Tukey post hoc test (A, C through H, and J): Kruskal–Wallis ANOVA (normality was assessed using the Shapiro–Wilk test): not statistically 
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Figure 5. Effects of high-fat diet (HFD; HFD32%) feeding on insulin resistance, weight of the 
mice, endothelial function, and nitrite and nitrate concentration in plasma in E3L.CETP mice.
Blood glucose concentration 0, 15, 30, 45, 60, and 120 minutes after glucose administration 
(A), changes in mouse weight (B, WeightEnd−WeightStart/WeightStart), changes in end-diastolic 
volume of the thoracic aorta (TA; C, TA-Ach), and abdominal aorta (AA; D, AA-Ach) 25 minutes 
after acetylcholine (Ach) administration as well as changes in nitrite (E: NO−
2
) and nitrate (F: NO−
3
) 
concentration in plasma in E3L.CETP mice fed a HFD (HFD32% white columns with horizontal 
lines or triangles) for 2 (B through F) and 16 (A) weeks (n=8) in comparison to age-matched 
C57BL/6J mice fed a standard diet (black columns with horizontal lines or circles, n=6, A, B, E, 
and F; n=5, C and D). Statistics: (A): repeated measures ANOVA, (B, E, and F): Mann–Whitney 
U test, (C and D): Student t test (normality was assessed using the Shapiro–Wilk test): not 
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we used a murine model for hyperlipidemia and ath-
erosclerosis (E3L.CETP mice27,28), which is based on 
the introduction of 3 human genes: apolipoprotein 
E*3 Leiden, apolipoprotein C1, and CETP.27,50 These 
mice exhibit a human-like lipoprotein metabolism51 
and respond similarly to humans to pharmacological 
interventions modulating lipid metabolism.52,53 We 
demonstrated that in E3L.CETP mice fed a HFD32%, 
endothelial function was also significantly impaired 
after just 2 weeks of feeding in the AA but not in TA, 
as evidenced on paradoxical vasoconstriction in AA 
with preserved response to Ach in TA. Importantly, 
E3L.CETP mice exposed to a HFD32% did not develop 
significant insulin resistance in contrast to C57BL/6 
HFD60%-fed mice, indicating that early vascular dys-
function induced by HFD is not dependent on sys-
temic insulin resistance. In the present study, mild 
insulin resistance was only observed in E3L.CETP fe-
male mice after 16 weeks of feeding with an HFD32% 
but not after 2  weeks (H.M.G. Princen, PhD, et al, 
unpublished data, 2004). Moreover, even diets with 
a higher fat content (60 kcal% or 45 kcal%) induced 
systemic insulin resistance in E3L.CETP mice only 
after a longer period of feeding than 2 weeks.28,54,55 
Similarly to HFD60% in C57Bl/6, E3L.CETP mice fed 
a HFD32% did not display a lower nitrite plasma con-
centration despite significant impairment of endothe-
lial function in the AA, pointing again to a local, not 
systemic nature of early-phase endothelial dysfunc-
tion in HFD-fed mice involving intercellular commu-
nication between endothelial cells and PVAT in the 
vessel wall in HFD–induced vascular pathology.56
CONCLUSIONS
We demonstrated here that short-term feeding with a 
HFD in 2 different mouse models resulted in the im-
pairment of the vascular response in the AA, whereas 
this response was largely preserved in the TA. The 
heterogeneous endothelial response was ascribed to 
distinct PVAT composition, including white adipose tis-
sue–like characteristics in the AA and brown adipose 
tissue–like characteristics in the TA, but was not asso-
ciated with systemic insulin resistance or with classical 
systemic biomarkers of endothelial dysfunction. These 
data underscore the notion that PVAT plays a funda-
mental role in the modulation of endothelial function 
in mouse models of metabolic syndrome and obesity, 
which could also be relevant to mechanisms of early en-
dothelial dysfunction induced by fat load in humans.57 
Finally, our results also support the proposal that PVAT-
targeted diagnosis58,59 and therapy60,61 might offer 
a novel approach to prevent residual vascular risks 
linked to the loss of PVAT-dependent homeostatic and 
vasoprotective function in response to excessive fat 
load, leading to endothelial dysfunction.62,63
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Figure S1. Algorithm for assessment of brown and white adipose tissue content in perivascular adipose 
tissue of thoracic and abdominal aorta.  
 
The representative images of aorta cross-section with perivascular adipose tissue (PVAT) simultaneously  stained 
for UCP-1 and perilipin (A). Separation of the channels for Cy3- based immunofluorescence of UCP-1 and FITC-
based immunofluoresence of perilipin are shown in (B) and (C) respectively. For quantitative analysis, the images 
of cross-section of PVAT were segmented in Ilastik software to assess the ratio of brown adipose tissue (BAT) to 
total fat tissue area. The result of an Ilastik segmentation are shown in (D,E). Red (D) indicates BAT (UCP-1 
positive area) while green (E) indicates WAT (perilipin positive area) and both corresponds directly to the 
immunopositive pixels in respective channels. The number of pixels representing UCP-1 and perylipin were 
counted using ImageJ software. The results were expressed as the ratio of brown adipose tissue area (number of 
UPC-1 immunopositive pixels) to the total adipose tissue area (sum of UCP-1+ perylipim immunopositive pixels), 
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Figure S2. Effects of high-fat diet (HFD60%) feeding on arterial stiffness measured as pulse wave velocity 
(PWV). 
 
Pulse wave velocity (PWV) in the thoracic (TA, A) and the abdominal (AA, B) aorta in C57BL/6 mice fed a high-
fat diet (HFD60%, white columns) for 2 (n=6, A; n=5, B), 4 (n=9, A; n=8, B) and 8 (n=7) weeks in comparison to 
age-matched C57BL/6 mice fed a control diet (black columns, after 2 (n=7),  4 (n=9) and 8 (n=7, B; n=6, A) weeks 
of feeding). Statistics: two-way ANOVA followed by Tukey’s post hoc test (normality was assessed using the 
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Figure S3. Effects of high-fat diet (HFD60%) feeding on adipose tissue immunohistochemical characteristics. 
 
Ratio of immunopositive pixels for lectin (A, B) and phosphorylated endothelial nitric oxide synthase (PeNOS, 
C, D) to total adipose tissue area in the thoracic (A, C) and the abdominal aorta (B, D) in C57BL/6 mice fed a 
high-fat diet (HFD60%, white columns) for 2 weeks (n=17, A; n=15, B; n=14, C; n=13, D) in comparison to age-
matched C57BL/6 mice fed a control diet (black columns, n=18, D; n=17, A; n=15, B; n=14, C). Statistics: two-
way ANOVA followed by Tukey’s post hoc test (normality was assessed using the Shapiro-Wilk test): ns - not 
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Averaged Raman spectra and analysis of the lipid unsaturation degree (I1660/I1444) of the thoracic perivascular 
adipose tissue (A: TA-PVAT), abdominal perivascular adipose tissue (B: AA-PVAT), interscapular (C: iBAT) 
and epididymal adipose tissue (D: eWAT) in C57BL/6 mice fed a HFD60% for 4 weeks (red columns and lines; 
n=5) in comparison to age-matched C57BL/6 mice fed a control diet (blue columns and lines, n=5). Statistics: 
Student's t-test (normality was assessed using the Shapiro-Wilk test): ns - not statistically significant * p<0.05, ** 
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